Pipeline
We are committed to developing first and best-in-class therapeutics for patients with high unmet need across a wide range of diseases.
We aim to discover and develop innovative therapeutics across a broad range of diseases to realize the transformative potential of previously undruggable targets. We are advancing an internal pipeline of programs in rare genetic diseases, immune-mediated diseases and oncology. Collaborations with biopharma partners are a critical part of our strategy, giving us additional opportunities to leverage the RAPID platform to address patient needs, including in therapeutic areas outside of our current internal focus.
